0001104659-21-087828.txt : 20210630 0001104659-21-087828.hdr.sgml : 20210630 20210630212826 ACCESSION NUMBER: 0001104659-21-087828 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210630 FILED AS OF DATE: 20210630 DATE AS OF CHANGE: 20210630 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOODMAN JONATHAN R. CENTRAL INDEX KEY: 0001868590 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39373 FILM NUMBER: 211063706 MAIL ADDRESS: STREET 1: 4850 WEST 78TH STREET CITY: INDIANAPOLIS STATE: IN ZIP: 46268 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: POINT Biopharma Global Inc. CENTRAL INDEX KEY: 0001811764 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 850800493 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4850 WEST 78TH STREET CITY: INDIANAPOLIS STATE: IN ZIP: 46268 BUSINESS PHONE: (647) 401-2182 MAIL ADDRESS: STREET 1: 4850 WEST 78TH STREET CITY: INDIANAPOLIS STATE: IN ZIP: 46268 FORMER COMPANY: FORMER CONFORMED NAME: Therapeutics Acquisition Corp. DATE OF NAME CHANGE: 20200511 4 1 tm2121126-15_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2021-06-30 0 0001811764 POINT Biopharma Global Inc. PNT 0001868590 GOODMAN JONATHAN R. 4850 WEST 78TH STREET INDIANAPOLIS IN 46268 1 0 0 0 Common Stock 2021-06-30 4 A 0 21523 A 21523 D Common Stock 2021-06-30 4 A 0 35872 A 35872 I Long Zone Holdings Inc. Stock Option (Right to Buy) 6.97 2021-06-30 4 A 0 35872 0.00 A 2026-12-01 Common Stock 35872 35872 D On June 30, 2021, POINT BIOPHARMA GLOBAL INC. (f/k/a Therapeutics Acquisition Corp., the "Issuer") consummated a business combination (the "Business Combination") pursuant to which RACA, Bodhi Merger Sub, Inc., a wholly-owned subsidiary of the Issuer merged with and into POINT Biopharma Inc., ("Old POINT"). At the effective time of the Business Combination, each share of Old POINT outstanding as of immediately prior to the effective time was exchanged for shares of Common Stock of the Issuer based on an implied Old POINT vested equity value of $585,000,000. As a result, the Reporting Person received the reported shares of the Issuer's Common Stock in consideration for the equity securities of Old POINT held by the Reporting Person prior to the Business Combination. A corporation controlled by Reporting Person At the effective time of the Business Combination, each option to acquire shares of Old POINT was exchanged for an option to acquire shares of Common Stock of the Issuer based on an implied Old POINT vested equity value of $585,000,000. As a result, the Reporting Person received the reported options to acquire the Issuer's Common Stock in consideration for the options to acquire equity securities of Old POINT held by the Reporting Person prior to the Business Combination. The option vests 25% on December 1, 2021 with the remaining 75% vesting in three equal annual installments thereafter. William L. Demers, by Power of Attorney for Jonathan R. Goodman 2021-06-30